SBI Securities
CAPR icon

SBI Securities’s Capricor Therapeutics CAPR Stock Holding History

SBI Securities’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$249K Buy
26,310
+23,495
+835% +$260K 0.01% 593
2026
Q2 		$67.8K Sell
2,815
-2,128
-43% -$64.5K ﹤0.01% 1062
2026
Q1 		$150K Buy
4,943
+4,809
+3,589% +$128K ﹤0.01% 719
2025
Q4 		$3.87K Buy
134
+67
+100% +$875 ﹤0.01% 2126
2025
Q3 		$483 Sell
67
-36
-35% -$265 ﹤0.01% 2983
2025
Q2 		$1.02K Buy
103
+99
+2,475% +$1.05K ﹤0.01% 2669
2025
Q1 		$38 Buy
4
+2
+100% +$28 ﹤0.01% 3712
2024
Q4 		$28 Buy
+2
New +$35 ﹤0.01% 3761

Other funds holding CAPR

Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Black Diamond Financial
Black Diamond Financial Towson, Maryland $1.18B AUM 15.24% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
VestGen Advisors
VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return
NBC Securities
NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
GoalVest Advisory
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SBI Securities's CAPR Position: Q3 2026 in Review

SBI Securities increased its Capricor Therapeutics (CAPR) stake by 835% in Q3 2026, buying an estimated $260K and bringing the position to 26,310 shares worth $249K. The position accounts for 0.01% of the portfolio, ranked #593.

SBI Securities first reported a position in CAPR in Q4 2024 and has held it in 8 quarters since. 25 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • SBI Securities held 26,310 shares of Capricor Therapeutics worth $249K as of Q3 2026.
  • SBI Securities bought 23,495 Capricor Therapeutics shares in Q3 2026, an estimated $260K.
  • Capricor Therapeutics made up 0.01% of SBI Securities's portfolio in Q3 2026, its #593 holding.
  • SBI Securities first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • 25 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.